Literature DB >> 11740682

Disseminated intravascular coagulation in trauma patients.

S Gando1.   

Abstract

Disseminated intravascular coagulation (DIC) is characterized by the in vivo activation of the coagulation system, which results in the intravascular deposition of fibrin and consumption bleeding. DIC is a serious hemostatic complication of trauma. It can be clearly distinguished from physiological hemostatic response to trauma by using sensitive coagulofibrinolytic molecular markers. Physiological hemostasis to injuries is similar in all kinds of trauma without exception. There is an increase in circulating proinflammatory cytokines in DIC patients after trauma. Elevated cytokines induce tissue factor-mediated activation of coagulation, suppression of the anticoagulant pathway, and plasminogen activator inhibitor-1 (PAI-1)-mediated inhibition of fibrinolysis followed by disseminated fibrin deposition in the microvasculature. In addition to the occlusive microvascular thrombosis and hypoxia, sustained systemic inflammatory response characterized by neutrophil activation and endothelial damage plays a pivotal role in the development of multiple organ dysfunction syndrome (MODS) in posttrauma DIC patients. DIC associated with sustained systemic inflammatory response syndrome (SIRS) after trauma leads to the development of MODS, which is the main determinant of patients' outcome after trauma.

Entities:  

Mesh:

Year:  2001        PMID: 11740682     DOI: 10.1055/s-2001-18864

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  33 in total

Review 1.  Tissue factor and thrombosis: The clot starts here.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

2.  Transforming growth factor-β in stem cells and tissue homeostasis.

Authors:  Xin Xu; Liwei Zheng; Quan Yuan; Gehua Zhen; Janet L Crane; Xuedong Zhou; Xu Cao
Journal:  Bone Res       Date:  2018-01-31       Impact factor: 13.567

3.  High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.

Authors:  D H Lee; B K Lee; S M Noh; Y S Cho
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-18       Impact factor: 3.693

4.  Feasibility of using hyperosmolar mannitol as a liquid tumor embolization agent.

Authors:  Lei Feng; Beverly A Kienitz; Carolyn Matsumoto; Jeffrey Bruce; Michael Sisti; Hoang Duong; John Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

5.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

6.  The acute coagulopathy of trauma is due to impaired initial thrombin generation but not clot formation or clot strength.

Authors:  Jeffrey N Harr; Ernest E Moore; Max V Wohlauer; Nathan Droz; Miguel Fragoso; Anirban Banerjee; Christopher C Silliman
Journal:  J Surg Res       Date:  2011-04-17       Impact factor: 2.192

7.  Efficacy of a high FFP:PRBC transfusion ratio on the survival of severely injured patients: a retrospective study in a single tertiary emergency center in Japan.

Authors:  Daisuke Kudo; Junichi Sasaki; Satoshi Akaishi; Satoshi Yamanouchi; Tomoaki Koakutsu; Tomoyuki Endo; Takeaki Sato; Ryosuke Nomura; Hironao Yuzawa; Michio Kobayashi; Yotaro Shinozawa; Shigeki Kushimoto
Journal:  Surg Today       Date:  2013-02-19       Impact factor: 2.549

Review 8.  Transfusion management of trauma patients.

Authors:  Beth H Shaz; Christopher J Dente; Robert S Harris; Jana B MacLeod; Christopher D Hillyer
Journal:  Anesth Analg       Date:  2009-06       Impact factor: 5.108

9.  In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1.

Authors:  Jasimuddin Ahamed; Nathalie Burg; Keiji Yoshinaga; Christin A Janczak; Daniel B Rifkin; Barry S Coller
Journal:  Blood       Date:  2008-06-10       Impact factor: 22.113

Review 10.  Thrombelastography and tromboelastometry in assessing coagulopathy in trauma.

Authors:  Pär I Johansson; Trine Stissing; Louise Bochsen; Sisse R Ostrowski
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-23       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.